Replies to post #605250 on NorthWest Biotherapeutics Inc (NWBO)

[jfr1611]

Extrooper,

As far as I know, NWBO is a listed company.
It’s much easier to buy a private entity than a public entity.
What you seems to forget is a premium on a public entity rarely exceed 100%.
How a BP can justify to its shareholders to pay 1,600% premium to acquire NWBO at $10?
It doesn’t make sens when the stock is sitting at $,60.
It does when the stock will be trading at $5,0.

Ps
I’m a banker for 30 years, acting as head of capital markets for a large bank.
Pps
I’m long the stock and I have bot more last week.